436 related articles for article (PubMed ID: 30813884)
1. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
[TBL] [Abstract][Full Text] [Related]
2. Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies.
Lauxmann S; Verbeek NE; Liu Y; Zaichuk M; Müller S; Lemke JR; van Kempen MJA; Lerche H; Hedrich UBS
Hum Mutat; 2018 Dec; 39(12):1942-1956. PubMed ID: 30144217
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
[TBL] [Abstract][Full Text] [Related]
4. SCN2A channelopathies: Mechanisms and models.
Hedrich UBS; Lauxmann S; Lerche H
Epilepsia; 2019 Dec; 60 Suppl 3():S68-S76. PubMed ID: 31904120
[TBL] [Abstract][Full Text] [Related]
5. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
[TBL] [Abstract][Full Text] [Related]
6. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
[TBL] [Abstract][Full Text] [Related]
8. Opposing Effects on Na
Ben-Shalom R; Keeshen CM; Berrios KN; An JY; Sanders SJ; Bender KJ
Biol Psychiatry; 2017 Aug; 82(3):224-232. PubMed ID: 28256214
[TBL] [Abstract][Full Text] [Related]
9. Confirming an expanded spectrum of SCN2A mutations: a case series.
Matalon D; Goldberg E; Medne L; Marsh ED
Epileptic Disord; 2014 Mar; 16(1):13-8. PubMed ID: 24659627
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic spectrum of SCN2A-related epilepsy.
Reynolds C; King MD; Gorman KM
Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
[TBL] [Abstract][Full Text] [Related]
11. Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.
Berecki G; Howell KB; Heighway J; Olivier N; Rodda J; Overmars I; Vlaskamp DRM; Ware TL; Ardern-Holmes S; Lesca G; Alber M; Veggiotti P; Scheffer IE; Berkovic SF; Wolff M; Petrou S
Commun Biol; 2022 May; 5(1):515. PubMed ID: 35637276
[TBL] [Abstract][Full Text] [Related]
12. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
[TBL] [Abstract][Full Text] [Related]
13. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
14. Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.
Que Z; Olivero-Acosta MI; Zhang J; Eaton M; Tukker AM; Chen X; Wu J; Xie J; Xiao T; Wettschurack K; Yunis L; Shafer JM; Schaber JA; Rochet JC; Bowman AB; Yuan C; Huang Z; Hu CD; Trader DJ; Skarnes WC; Yang Y
J Neurosci; 2021 Dec; 41(49):10194-10208. PubMed ID: 34716231
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons.
Asadollahi R; Delvendahl I; Muff R; Tan G; Rodríguez DG; Turan S; Russo M; Oneda B; Joset P; Boonsawat P; Masood R; Mocera M; Ivanovski I; Baumer A; Bachmann-Gagescu R; Schlapbach R; Rehrauer H; Steindl K; Begemann A; Reis A; Winkler J; Winner B; Müller M; Rauch A
Hum Mol Genet; 2023 Jun; 32(13):2192-2204. PubMed ID: 37010102
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
Wolff M; Brunklaus A; Zuberi SM
Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
[TBL] [Abstract][Full Text] [Related]
17. Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties.
Thompson CH; Potet F; Abramova TV; DeKeyser JM; Ghabra NF; Vanoye CG; Millichap JJ; George AL
J Gen Physiol; 2023 Oct; 155(10):. PubMed ID: 37578743
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
19. Differential Functional Changes of Nav1.2 Channel Causing
Miao P; Tang S; Ye J; Tang J; Wang J; Zheng C; Li Y; Feng J
Front Neurol; 2021; 12():653517. PubMed ID: 34093402
[No Abstract] [Full Text] [Related]
20. Pathogenic variants in KCNQ2 cause intellectual deficiency without epilepsy: Broadening the phenotypic spectrum of a potassium channelopathy.
Mary L; Nourisson E; Feger C; Laugel V; Chaigne D; Keren B; Afenjar A; Billette T; Trost D; Cieuta-Walti C; Gerard B; Piton A; Schaefer E
Am J Med Genet A; 2021 Jun; 185(6):1803-1815. PubMed ID: 33754465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
